## OXY: Occidental Petroleum Corporation - XLE: Energy

### Executive Summary

No thesis match: MRS_20 -0.2% below STRENGTH zone (4.0-10.0%); PEG 2.45 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-1.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($38.85)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Is Occidental Petroleum (OXY) Pricing Reflecting Its Large DCF Upside?**
- Source: Simply Wall Street | 20260105T110841 | Bullish | Relevance: 100%
- This article analyzes Occidental Petroleum's (OXY) valuation using Discounted Cash Flow (DCF) and Price-to-Earnings (P/E) approaches. The DCF model indicates that OXY is significantly undervalued, suggesting an intrinsic value of $105.31 per share compared to its current price of $42.38. However, the P/E ratio suggests the stock is overvalued relative to its industry and fair ratio, trading at 28.6x compared to a fair ratio of 16.6x.

**2. Occidental Petroleum stock rises premarket: OXY climbs after $9.7B OxyChem sale â€” what investors watch next**
- Source: ts2.tech | 20260105T102226 | Somewhat-Bullish | Relevance: 100%
- Occidental Petroleum (OXY) shares rose in premarket trading following the completion of its $9.7 billion sale of the OxyChem unit to Berkshire Hathaway. Investors are focusing on how the company will deploy this cash to address leverage and enhance shareholder returns, particularly as oil prices remain volatile. The sale aims to sharpen Occidental's focus on its core oil-and-gas operations, although analyst sentiment remains mixed and concerns about future oil price weakness and retained legacy liabilities persist.

**3. Occidental Completes Sale of OxyChem**
- Source: euro-petrole.com | 20260105T101026 | Bullish | Relevance: 100%
- Occidental has announced the completion of the sale of its chemical business, OxyChem, to Berkshire Hathaway for $9.7 billion in cash. This transaction aims to strengthen Occidental's balance sheet and allow the company to focus on its oil and gas portfolio. Occidental subsidiary Environmental Resource Holdings, LLC (ERH) will retain OxyChem's legacy tort claims and environmental liabilities.

**4. 10 Best Natural Gas Stocks to Buy Right Now**
- Source: Insider Monkey | 20260107T061017 | Bullish | Relevance: 100%
- This article discusses some of the best natural gas stocks, focusing on Occidental Petroleum Corporation (NYSE: OXY). It details OXY's strategic sale of its chemical business (OxyChem) to Berkshire Hathaway for $9.7 billion, a move aimed at debt reduction and strengthening its balance sheet. The company plans to reinvest the proceeds into its core oil and gas assets, particularly in the Permian Basin, Gulf of America, and Oman.

**5. Occidental Is Trading Above 50-Day SMA: How to Play the Stock?**
- Source: Finviz | 20260107T171131 | Somewhat-Bullish | Relevance: 96%
- Occidental Petroleum (OXY) is showing a bullish trend, trading above its 50-day simple moving average. The company is benefiting from its focus on the Permian Basin, contributions from recent acquisitions, and debt reduction following the sale of its chemical business for $9.7 billion. Despite headwinds like volatile commodity prices and declining earnings estimates, its robust U.S. operations and Permian Basin presence make it a Zacks Rank #3 (Hold) stock.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-12 | UBS | $43 | $45 | -4% |
| 2025-12-11 | B of A Securiti | $44 | $45 | -2% |
| 2025-12-08 | JP Morgan | $44 | $51 | -14% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-12 | UBS | main | Neutral |
| 2025-12-11 | B of A Securiti | main | Neutral |
| 2025-12-08 | JP Morgan | down | Underweight |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 1 ($0.19M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 59.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 5 / 3 |

**Top Holders:**
- Berkshire Hathaway, : 26.9% (0.0%)
- Vanguard Group Inc: 9.1% (+0.8%)
- Dodge & Cox Inc.: 8.1% (-0.5%)
- Blackrock Inc.: 5.0% (+3.4%)
- State Street Corpora: 3.9% (-0.9%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.45 elevated, pricing in significant growth expectations. Balance sheet: $1.0B free cash flow. Revenue declining -18% YoY, concerning. Analyst sentiment negative (3 target cuts vs 0 raises). Institutional flow bullish (5 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $40.4B |
| Beta | 0.38 |
| 52W Range | $34.78 - $53.20 |
| Short Interest | 5.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.45 |
| Forward P/E | 26.7 |
| Current P/E | 18.2 |
| YoY Growth | -32.0% |
| EPS Direction | STABLE |

### Technicals

MRS_20 deteriorating from 1.4% to -0.2% (-1.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 4.2pp (needs >4.0% for momentum thesis). Below SMA200 (0.95x), long-term trend not supportive. RSI neutral at 49. Elevated volume (1.5x 20MA), institutional activity likely. OFD pattern: -MTN (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -0.23% (CS: 51) | Neutral |
| RSI_14 | 49.4 | Neutral |
| MACD Histogram | 0.18 | Bullish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 0.995x | Below |
| vs SMA200 | 0.952x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $40.99
- **Stop Loss:** $38.85 (5.2% risk)
- **Target:** $43.13 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 467
- **Position Value:** $19,142.33
- **Portfolio %:** 19.14%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk appetite. VIX at 15.38 sits in the normal range (18th percentile of 52-week) with modest upward drift, while yield curve remains positively sloped (+62bps 10Y-3M) supporting risk assets. Breadth at 59.5% shows healthy participation, though elevated put/call ratio (1.12) suggests some hedging activity. FOMC 20 days out provides runway for current conditions to persist.*

### Earnings

**Next:** 2026-02-17 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.50 | $0.64 | +26.8% |
| 2025Q2 | $0.31 | $0.39 | +24.8% |
| 2025Q1 | $0.76 | $0.87 | +14.0% |
| 2024Q4 | $0.67 | $0.80 | +19.4% |

---
*RULE-based L3 | 2026-01-08 08:02 | MRS_20*